Skip to main content
  • Sign in
  • Help
BOPA
  • Why join BOPA
  • Pricing
  • Education
    • BOPA Introduction to Cancer Course 2026
    • Courses and eLearning
    • SACT Verification Hub (Passport)
    • Resource Library
    • Cancer Hub
    • Education & Training Standards
    • Let’s Talk About SACT – a BOPA Podcast
  • About BOPA
    • About BOPA
    • Welcome to BOPA
    • Executive Committee
    • Subcommittees & working groups
    • Affiliated Groups
    • Cancer Advisory Groups & Specialist Interest Groups
    • International Groups
    • BOPA Fellows
    • Corporate Membership
    • BOPA membership FAQs
  • Conference
    • Latest Conference 2026
    • Abstract Submission
    • Past Symposiums / Conferences
  • News & Events
    • UKPPLB Open Letter
    • News
    • Events calendar
    • Submit event
  • Menu iconLCC
    • LCC
    • Cancer Hub
  • Menu iconBOPA/IOCN Monographs
  • Join BOPA
Join BOPA
BOPA Join BOPA
  • Why join BOPA
  • Pricing
  • Education
    • BOPA Introduction to Cancer Course 2026
    • Courses and eLearning
    • SACT Verification Hub (Passport)
    • Resource Library
    • Cancer Hub
    • Education & Training Standards
    • Let’s Talk About SACT – a BOPA Podcast
  • About BOPA
    • About BOPA
    • Welcome to BOPA
    • Executive Committee
    • Subcommittees & working groups
    • Affiliated Groups
    • Cancer Advisory Groups & Specialist Interest Groups
    • International Groups
    • BOPA Fellows
    • Corporate Membership
    • BOPA membership FAQs
  • Conference
    • Latest Conference 2026
    • Abstract Submission
    • Past Symposiums / Conferences
  • News & Events
    • UKPPLB Open Letter
    • News
    • Events calendar
    • Submit event
  • Menu iconLCC
    • LCC
    • Cancer Hub
  • Menu iconBOPA/IOCN Monographs
  • Join BOPA

Home » Abstracts

Abstracts

BOPA encourages its members to share helpful documents that can benefit other members.  BOPA respects the intellectual property of original authors and requires anyone who uses other members’ work to include an acknowledgment of, or reference to, the source in their version.

DISCLAIMER:
BOPA is not the author or owner of some of the documents published on our website.  BOPA as a professional interest group will share documents via its website that are of interest to BOPA members, but has no responsibility for use of the documents and for any recommendations within the documents so members must use these at their discretion. BOPA cannot accept responsibility for any errors or omissions or for any consequences from application of information in the documents attached and make no warranty, expressed or implicit with respect to the contents of this webpage. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site or document(s) downloaded from it.

Posters and abstracts on the BOPA website remain the property of the authors and anyone wishing to reference or share this work must contact the authors directly. Abstracts subsequently published in JOPP follow copyright rules from JOPP.

Last reviewed: 20/10/20 by Jonathan Barrett

39 ABSTRACT Re-Audit to assess improvement in Abiraterone monitoring during the first 3 months of treatment

Abstracts

View resources
Last reviewed: 20/10/20 by Jonathan Barrett

39 POSTER Re-Audit to assess improvement in Abiraterone monitoring during the first 3 months of treatment

Abstracts

View resources
Last reviewed: 20/10/20 by Hiten Lad

40 ABSTRACT Drug History Alerts (DHA) – A project to improve the efficiency of prescription validation and screening of drug interactions and ECGs prior to patients receiving systemic anti-cancer therapy (SACT)

Abstracts

View resources
Last reviewed: 20/10/20 by Hiten Lad

40 POSTER Drug History Alerts (DHA) – A project to improve the efficiency of prescription validation and screening of drug interactions and ECGs prior to patients receiving systemic anti-cancer therapy (SACT)

Abstracts

View resources
Last reviewed: 17/03/21 by Arif Meghani

43 ABSTRACT Rixathon® (Biosimilar Rituximab) Infusion Related Reaction Monitoring Audit

Abstracts

View resources
Last reviewed: 17/03/21 by Arif Meghani

43 POSTER Rixathon® (Biosimilar Rituximab) Infusion Related Reaction Monitoring Audit

Abstracts

View resources
Last reviewed: 20/10/20 by Arif Meghani

44 ABSTRACT Single Centre experience of implementing Olanzapine for preventing chemotherapy induced nausea and vomiting (CINV) in patients with Early Beast Cancer

Abstracts

View resources
Last reviewed: 20/10/20 by Arif Meghani

44 POSTER Single Centre experience of implementing Olanzapine for preventing chemotherapy induced nausea and vomiting (CINV) in patients with Early Beast Cancer

Abstracts

View resources
Last reviewed: 20/10/20 by Anna Wong

45 ABSTRACT A study at North Bristol NHS Trust (NBT) to assess the feasibility of patients self-administering subcutaneous bortezomib at home

Abstracts

View resources
Last reviewed: 20/10/20 by Anna Wong

45 POSTER A study at North Bristol NHS Trust (NBT) to assess the feasibility of patients self-administering subcutaneous bortezomib at home

Abstracts

View resources
Last reviewed: 20/10/20 by Lorna Cairns

15 ABSTRACT Medicines Optimisation for Oncology Patients Receiving Chemotherapy

Abstracts

View resources
Last reviewed: 20/10/20 by Lorna Cairns

15 POSTER Medicines Optimisation for Oncology Patients Receiving Chemotherapy

Abstracts

View resources

Filter for resources

  • Types

  • Tags

  • Reset

Previous 1 … 32 33 34 35 Next
BOPA logo
  • Why join BOPA
  • Pricing/Join
  • Latest Conference 2026
  • Education
  • About
  • News & Events
  • Help
  • Go to LinkedIn
  • Go to Twitter
  • Go to Facebook
  • Go to Instagram
  • Go to Bluesky

© Copyright 2026 British Oncology Pharmacy Association.
Registered Charity No. 1065026

  • Privacy Policy
  • T&Cs Website
  • T&Cs Membership
  • Cookies
  • Contact
Designed and developed by Rouge
Our website uses cookies to distinguish you from other users of our website. This helps us to provide you with a good experience when you browse our website and also allows us to improve our site. By continuing to browse the site, you are agreeing to our use of cookies.